The temptation to prescribe broadly particularly when GLP-1 services offer an attractive income stream must be tempered by sound clinical judgment
It is recommended to take with a glass of water
Unlike orlistat, which blocks fat absorption, or phentermine, which is a stimulant-based appetite suppressant, GLP-1 receptor agonists address hunger and satiety at the hormonal level, targeting a fundamental aspect of overeating
Combining it with another GLP-1 or GIP agonist (semaglutide, tirzepatide) would compound the same receptor load and the same GI and hypoglycemia risks with no efficacy evidence to support it
doi: 10.13702/j.1000-0607.20211016 62
About 65 percent of people actually report positive things such as feeling lighter, being less inflamed, being less reactive to a variety of substances, and having more energy, within the first week or so